Document is current
Any future updates will be listed below
-
Authors
Shen, Jing
Begum, Najida
Ruiz-Garcia, Yara
Martinon-Torres, Federico
Bekkat-Berkani, Rafik
Meszaros, Kinga
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 18 April 2022
First Online: 31 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: KM, YRG and RBB are employees in the GSK group of companies. KM, RBB hold shares in the GSK group of companies. JS was employee and hold share in the GSK group of companies during the conduct of the study. NB is a freelance consultant for the GSK group of companies and therefore received consulting fees during the conduct of the study. FMT reports personal fees, non-financial support and/or grants from Ablynx, Jansen, GSK, Regeneron, Medimmune, Pfizer, MSD Sanofi Pasteur, Novavax, Astra Zeneca, Novartis, Seqirus, Roche, Abott, Instituto de Salud Carlos III and Biofabri, outside the submitted work. JS, NB, YRG, FMT, RBB and KM declare no other financial and non-financial relationships and activities.
